Many different imaging modalities and techniques have been used in the past for the diagnosis of renal artery stenosis. The ideal accurate, non-invasive and inexpensive diagnostic test has yet to be found but there have been promising developments during the last few years. In this review we consider in detail the use of the following tests for the diagnosis of renal artery stenosis; intravenous urography, B Mode ultrasound, Doppler ultrasound, renal scintigraphy with angiotensin-converting
Introduction
Renal artery stenosis (RAS) remains the commonest curable cause of hypertension and is a significant cause of end-stage renal failure. In the young hypertensive patient a diagnosis of RAS caused by fibromuscular dysplasia is unusual but must be considered in the appropriate clinical circumstances. In the United Kingdom there is a much larger group of patients with RAS caused by atherosclerotic disease. A recent paper in this journal 1 considered whether it is worthwhile to diagnose atherosclerotic renal artery stenosis (ARAS). The authors concluded that patients with renovascular hypertension caused by ARAS should only be treated when there is true drug resistant hypertension and that the results of treatment for ARAS to halt progression of ischaemic renal failure are promising.
Much attention during the past 30 years has focused on the need to find an accurate, inexpensive and non-invasive diagnostic test for RAS. Radiology has evolved rapidly during this time. New, noninvasive diagnostic methods which can be used for RAS imaging such as ultrasound, computed tomography and magnetic resonance imaging have been developed. Interventional radiological techniques have been refined to use a lower radiation dose and smaller calibre catheters. In addition, non-surgical treatments such as renal angioplasty and renal artery stenting have become possible.
At present conventional arterial catheter angiography is the 'gold standard' diagnostic test for RAS. However, it is an expensive and invasive procedure associated with a measurable morbidity. In general, the non-invasive tests have previously had only a moderate level of sensitivity and specificity for RAS. Therefore these non-invasive imaging methods were used as screening tests to select those patients considered at sufficiently high risk of the disease to justify proceeding to catheter angiography for definite diagnosis. It is hoped that newer non-invasive techniques such as magnetic resonance angiography will combine both screening and definitive diagnostic roles. In this review we will discuss in detail the diagnostic tests which have previously been used for RAS and those which are currently being developed.
Imaging methods

Intravenous urography
The intravenous urogram (IVU) was first modified for use as a screening test for RAS nearly 40 years ago. 2, 3 It was thought that by taking X-ray films at 1, 2, 3, 4 and 30 min post contrast injection in addition to the conventional films at 5 and 15 min that certain features could be identified which would indicate renovascular hypertension. These features were believed to be related to reduced arterial blood flow and hyperconcentration of urine in the affected kidney. The specific appearance which were sought were disparity in renal length, delayed calyceal appearance and hyperconcentration of contrast on delayed films.
The largest series to favourably assess the use of the IVU in the diagnosis of RAS was the prospective, multi-institutional Cooperative study published in 1972. 4 However, the authors also concluded that the IVU was not able to distinguish between those patients who would respond favourably to surgical intervention and those who would not.
During the next decade several papers were pub-lished which questioned the use of the IVU in the diagnosis of renovascular hypertension. The most influential of these was published by Thornbury et al. 5 This was a large retrospective study from a single institution and the authors found a true positive rate for the diagnosis of RAS (greater than 50% stenosis) of only 58.4%. In addition they performed a re-analysis of the Cooperative study data using a more widely accepted, lower estimate of the incidence of reno-vascular disease in the general population than the 10% used in the original paper. The conclusion was that when used as a screening test for the detection of RAS (greater than 50%), the Cooperative study data showed a true positive rate for IVU of 78%.
In a later review it was calculated that the probability of renovascular hypertension in the general hypertensive population only increased from 1% to 5% when the patient had a positive IVU examination. This was concluded to be insufficient evidence for most clinicians to consider referral for catheter angiography. 6 The IVU involves the use of intravenous iodinated contrast material with the small associated risk of contrast reaction. The rare adverse effects are diverse including urticaria, nausea and vomiting and anaphylactoid reactions such as hypotension and cardiac arrest. 7 Iodinated contrast material is potentially nephrotoxic in diabetics and those with pre-existing renal impairment 8 and the IVU is associated with a significant effective radiation dose (equivalent to more than 200 chest X-rays). The IVU is not an invasive test but when used for detection of RAS results have been disappointing. The IVU is no longer considered an appropriate test in the investigation of suspected RAS.
9
Ultrasound
Conventional B Mode ultrasound (US) allows detailed assessment of the anatomy of the kidney and accurate measurement of renal size. It is an easily performed, inexpensive procedure which is well tolerated by patients. Although it was long accepted that a reduction in renal size was associated with RAS there was a paucity of formal reports on this subject in the literature for many years. This was due to the difficulty in performing natural history studies based on follow-up using invasive functional tests or arteriography. With the development of B Mode and Doppler US, non-invasive assessment of the natural history of RAS became possible. These studies demonstrated that over 20% of patients with greater than 60% stenosis of the main renal artery will sustain a reduction in renal length of at least 1 cm during a 2-year follow-up period. 10, 11 There are three main problems with the use of a measurement of renal length as a diagnostic test for renal artery stenosis. The first is the wide variation in normal renal length between subjects. 12 A confident diagnosis of abnormality is only possible if a previous US measurement is available to prove a reduction in length or where there is a marked reduction in renal length in the later stages of the disease. The second difficulty is the reduction in renal length and volume in normal subjects over 70 years of age 12 which is believed to be due to a decrease in the number of glomeruli and a reduction in the mass of the juxtamedullary nephrons. 13 The other problem is that a reduction in renal length can be caused by many other chronic renal parenchymal diseases. Therefore measurement of renal length is both a relatively insensitive and non-specific test for RAS.
Although it is not a good diagnostic test for RAS it is possible to justify the use of B Mode US in the general investigation of hypertensive patients to exclude other renal disease, such as polycystic disease, chronic pyelonephritis and hydronephrosis.
Doppler US is a more complex technique, which has been developed during the past two decades to demonstrate patterns of blood flow. Recently, Doppler US has become much more widely available, easier to use and more accurate due to technological advances. It now has a well-established place in other areas of vascular imaging. There has been very considerable interest in Doppler US as a diagnostic technique for RAS because of its non-invasive nature and relatively low cost. However, despite extensive study the role of Doppler US in the screening, diagnosis and follow-up of RAS still remains unclear.
The basic principle of US is the use of the reflection of an inaudible sound beam by surfaces at different depths within the body to create a map of structure. Doppler US depends on detecting a change in the frequency of the ultrasound beam when the surface is a moving particle such as a blood cell (Doppler effect). A complex mathematical process is then used to convert this information into a map of flow in the area under assessment. Both the direction and velocity of flow are indicated by a colour code on the US screen. In addition, a detailed quantitative analysis of the waveform pattern of the blood flow in a smaller area such as a single vessel can be obtained as a graph.
The earliest studies of Doppler US for RAS diagnosis were a direct development of the technique which had already been successfully used to detect stenosis in carotid arteries. This depended on finding an increase in blood velocity at the stenosis site and turbulent flow just beyond the abnormal segment of the main renal artery. Various criteria that related to the peak systolic arterial velocity and ratio of renal artery to aortic peak systolic velocity were proposed for the detection of a haemodynamically significant stenosis. [14] [15] [16] Initial reports were encouraging, however during the next few years a wide range of accuracies for diagnosing or excluding RAS were reported 17 and it soon became clear that there were significant difficulties in the study of the main renal artery. The technique was time consuming and operator dependent. Inability to fully demonstrate technique was time consuming and operator dependent. Inability to fully demonstrate the vessel was reported in up to 40% of studies. 18, 19 This was due to various factors including patient obesity, respiratory motion, transmitted cardiac or aortic pulsation or to overlying bowel gas. If the vessel followed a tortuous course there was difficulty in demonstrating its entire length with confidence. There was further doubt about the validity of the technique when studies showed accessory renal arteries present angiographically in 14 -24% of kidneys and only 0-4% of these were shown with Doppler US. [18] [19] [20] Doppler US examination of the intra-renal arteries is much less technically challenging than assessment of the main renal artery. In 1986 Handa et al 21 first observed that changes occur in the waveform pattern of the intra-renal vessels beyond a renal artery stenosis. The waveform changes in the intrarenal vessels were observed to be of two basic types ( Figure 1 ). The first type manifested as a slowed rise to peak systolic velocity ('pulsus tardus phenomenon') and loss of the normally occurring early systolic velocity peak. [21] [22] [23] [24] The second type was a lowering of the renal resistive index (peak systolic velocity/maximum end diastolic velocity). 25, 26 These changes were shown to be result of a complex interaction between the resistance to flow and the compliance of the post-stenotic vessel wall. 27, 28 There have been many studies published on the use of intra-renal Doppler US to detect RAS. Results have been variable and a number of indices have been used to quantify the changes described above. Sensitivity of up to 92% and specificity of up to 95% for detection of severe RAS (greater than 70%) have been reported. [29] [30] [31] Generally, it was found that moderate renal artery narrowing (50-70%), did not produce convincing Doppler waveform changes in the intra-renal vessels. These studies also found that peripheral renal Doppler studies could not always reliably distinguish severe stenosis from complete occlusion. 17 In an effort to improve detection of RAS, it was suggested that an oral angiotensin-converting enzyme (ACE) inhibiting drug be added during the study. A similar approach had been previously used with some success in Nuclear Medicine examinations (see later for detail). In two studies, the use of an oral ACE inhibiting drug during the intrarenal Doppler US study was shown to improve the detection of moderate RAS (50-70%). 32, 33 However, the reproducibility of these results is uncertain and the mechanism of the effect on the Doppler waveform is the subject of considerable debate.
As discussed above, the intra-renal waveform alteration in RAS is partly dependent on vascular compliance. Therefore it is possible that a false positive result could be produced in a patient with reduced wall compliance such as occurs in atherosclerotic disease or with the normal loss of arterial wall elasticity during aging. This is one reason why research has been directed to improve visualisation of the main renal artery. The use of the main renal artery for assessment would also allow the use of the original, less complicated technical parameters for the detection of stenosis. During recent years, intravenous contrast media have been introduced for use with ultrasound. 34 These are of low toxicity and improve Doppler signal detection from both the main renal artery and intra-renal vessels. There are several types of intravenous contrast media under investigation. One of these is a galactose microparticle suspension containing microbubbles (Levovist, Schering, Berlin, Germany) which has been evaluated with promising results. 35 However, at present the use of Doppler US for the diagnosis of RAS is still perceived to be dependent on operator skill and experience. The technique has not gained widespread acceptance as a robust screening test for RAS in the general hypertensive population. It may have a role in more selected patient groups or to monitor treatment results in individual patients.
Renal scintigraphy with angiotensin-converting enzyme inhibitors
Renal scintigraphy involves the intravenous (i.v.) injection of complex molecules bound to radioactive markers (radiopharmaceuticals). The two most commonly used agents in imaging RAS are diethylenetriamine pentaacetic acid (DTPA) and mercaptoacetyltriglycine (MAG-3). Once these are attached to the isotope 99m technetium (labelled) they are given to the patient as an i.v. bolus and can be detected with a gamma camera. The labelled DTPA or MAG-3 is filtered by the kidney and excreted in the urine.
Dynamic counting of radioactivity, with regions of interest over the kidneys, allows us to study renal function. A computer creates the renogram curves which are processed enabling assessment of the split renal function, the time-to-peak-counts and the renal parenchymal transit time.
Haemodynamically significant RAS causes a reduction in renal perfusion. There is then activation of the renin-angiotensin system, resulting in elevated levels of angiotensin II (AT II). The glomerular filtration pressure and rate are maintained by AT II mediated efferent arteriolar vasoconstriction. However, AT II also causes systemic hypertension by increasing the tubular resorption of sodium, both directly and indirectly via increased aldosterone secretion, and by raising the total peripheral resistance via generalised arteriolar vasoconstriction. ACE inhibitors, which block the synthesis of AT II from angiotensin I, can theoretically unmask the activation of the renin-angiotensin system which may be detected by scintigraphy.
The basis of all methods of renal scintigraphy for the detection of RAS is to demonstrate delayed and decreased total activity over the affected kidney ( Figure 2 ). There is no consensus on the most effective protocol for the use of renal scintigraphy to detect RAS. 36, 37 Prior to the examination patients are usually fasted but allowed free fluids to maintain good hydration. Both baseline and/or ACE inhibition scintigraphy can be performed. If both studies are used a suitable time interval must elapse before the ACE inhibition scintigraphy is performed to allow clearance of the isotope. Patients are required to discontinue any oral diuretic and ACE inhibitor therapy for up to a week prior to baseline studies. A variety of commercially available ACE inhibitors are used for the ACE inhibition study, either taken orally approximately 1 h before examination, or administered i.v. about 10-15 min prior to the radiopharmaceutical. 36 Typically 25-50 mg of oral captopril is used. [38] [39] [40] Profound hypotension may follow the first dose of ACE inhibitor and therefore the blood pressure is monitored regularly and any hypotensive episodes treated appropriately.
In patients with RAS the abnormality on the renogram depends on the radiopharmaceutical used. DTPA is exclusively excreted by glomerular filtration and thus in the presence of RAS there is decreased uptake and excretion on the baseline study, more marked on the ACE inhibition study. MAG-3 is predominantly excreted by the renal tubules and thus significant stenosis results in a delayed transit time and persistent cortical activity.
The sensitivity and specificity of renal scintigraphy in the diagnosis of RAS are very variable. The results depend not only on correct patient selection but also on the radiopharmaceutical used and the method of interpretation of the renographic changes. Reported figures range from 34% to 100% for sensitivity and 72% to 95% for specificity. 37, 38, 41 Some authors rely on post ACE inhibition renograms only 40 and others feel that overall diagnostic accuracy has not been improved since the addition of ACE inhibitors. 39 The usefulness of renal scintigraphy as a diagnostic test for renal artery stenosis has recently been questioned. 39 Its negative predictive value is 72% and in one series a third of patients with proven renovascular hypertension had negative ACE inhibition scintigraphy. 42 The use of post-captopril renal scintigraphy for the prediction of response to intervention in RAS has shown more consistent results. A positive predictive value of between 90-97%, with a sensitivity of 87-93% and a specificity of 93-100% in predicting the blood pressure response to intervention have been found. 38, 43 Scintigraphic measurement of renal blood flow pre and post ACE inhibitors has also been investigated as a diagnostic tool but appears to be of limited value in diagnosing renovascular hypertension or predicting the response of blood pressure to intervention. 44 Overall the usefulness of ACE inhibition scintigraphy as a screening test for haemodynamically significant renal artery stenosis is questionable, although a positive result is a strong predictor of those patients who may respond to intervention.
Angiography
Angiography involves the injection of iodinated contrast material by the intra-arterial (i.a.) or intravenous (i.v.) route to define a vessel lumen. Conventional X-ray film-screen technology was used for many years as the standard technique for visualising and locating the anatomic lesions of renal artery stenosis during angiography. 45 Since the introduction of digital equipment most departments now perform digital subtraction angiography (DSA). 46 By using DSA all background detail such as the bony skeleton is removed from the image by computer. The resultant images show the vessel under study to best advantage and the technique is associated with a lower radiation dose than conventional filmscreen technology. At angiography, RAS lesions causing a greater than 50% reduction in the diameter of the vessel are assumed to be haemodynamically significant.
Intra-arterial angiography is an invasive technique most commonly involving femoral artery puncture under local anaesthesia. Transradial, transbrachial or transaxillary approaches are feasible but are associated with higher morbidity. 47, 48 A 5 French pigtail catheter is then usually introduced and a flush aortogram is obtained with the tip of the catheter above the level of the renal arteries. If necessary, selective renal angiograms are performed with a preshaped visceral catheter positioned within the origin of the renal artery. Most radiologists now use non-ionic contrast media 49 and a total of approximately 50-120 mls of contrast are injected via an automatic injector. The images are repeated at appropriate obliquities to demonstrate the origins of the vessels optimally.
The procedure is now routinely performed as a day-case, 50 with admission for a 3-6 h post-procedure recovery period. 46 Complications due to the technique include most commonly local haemorrhage and haematoma formation, which is seen in 15-20%, 51 arterial thrombosis and distant emboli, sepsis and arterial dissection. Iatrogenic aortic dissection is also reported rarely in elderly. 52 Late complications include false aneurysm or more rarely arteriovenous fistula formation at the puncture site. 51 There is a very small additional risk from the contrast media itself, as described in the IVU section above, although the introduction of low-osmolar non-ionic contrast media has reduced the overall rate of complications to approximately 44 cases per million examinations. 53 Although intra-arterial DSA is now accepted as the standard technique for diagnosing RAS ( Figure  3 ) it has its limitations. There is little information on the state of the vessel wall and eccentrically located stenoses may not be visible due to the limited number of planes of projection. There is also wide variation in the angle of origin of the renal arteries 54 and the proximal portions of the vessels are often superimposed over the aorta despite the use of oblique projections. Intra-venous DSA was introduced in the late 1970's as a less invasive alternative to conventional angiography and involves injection of iodinated contrast media into the antecubital vein or, following insertion of a catheter, into the superior vena cava, inferior vena cava or right atrium. 55 Studies have shown that good results can be obtained using intra-venous DSA for the diagnosis of RAS with sensitivities and specificities of 88-100% and 90-93% respectively. 56, 57 However, it cannot achieve equivalent resolution to conventional angiography and may miss up to 50% of cases of fibromuscular dysplasia and stenoses in small branch arteries. 58 In addition a larger volume of contrast is needed for each series of images increasing the risk of congestive cardiac failure and nephrotoxicity in patients with pre-existing renal impairment.
Computed tomographic angiography
Computed tomographic (CT) angiography is an evolving non-invasive method for imaging the renal vasculature. Unfortunately it does involve the use of both ionising radiation and intravenous iodinated contrast media. However, it has the advantage over angiography that it also provides anatomical and pathological information about the kidneys and adrenal glands. CT angiography can give additional information about the state of the vessel wall including mural calcification and plaques 59 and is less costly in time and staff resources than intraarterial angiography.
In order to evaluate the renal arteries adequately it is necessary to use a modern spiral (helical) CT scanner, rather than conventional CT. Spiral CT is not currently available in all centres. The spiral CT allows the acquisition of multiple contiguous slices in a 'block' during a single patient breath hold. These images can then be manipulated by computer to generate a 'three-dimensional' reconstruction block. In a conventional CT scanner only one image can be obtained during each breath hold. It is extremely difficult for the patient to achieve precisely the same degree of breath hold each time and as a result there is often uneven spacing of images. This creates considerable difficulty in the reconstruction of data. In addition, the intravenous injection of contrast must be maintained during the examination and this would require an unacceptably large volume of contrast using conventional CT.
The renal arteries are technically difficult to image using CT angiography due to the variation in their number and sites of origin. Although accessory renal arteries can arise as far cranially as the inferior phrenic artery and as far caudally as the median sacral artery, almost all arise from the abdominal aorta between the superior mesenteric artery and the aortic bifurcation. There is also considerable excursion of the kidneys and renal arteries during respiration and thus an appropriate area needs to be scanned during a single breath hold of about 30 sec. This area can be determined using a topogram or following localising uncontrasted transverse CT sections. 59 It can difficult to obtain adequate diagnostic images due to respiratory or movement artefact in patients with dyspnoea and those unable to lie still.
A three-dimensional volumetric acquisition of data is thus performed during a breath hold with simultaneous intra-venous contrast enhancement. Satisfactory renal artery visualisation depends on a high concentration of contrast within the vessel lumen, therefore a large volume (100-150 mls) of non-ionic iodinated contrast media is administered via an automatic injector with a cannula in an antecubital vein. This can be given at a fixed rate, following a fixed delay, depending on the age and weight of the patient. 60, 61 However, if possible it is preferable to use an individually calculated delay based on the transit time of a preliminary test injection of 15 mls of contrast to optimise contrast enhancement. 59 The large volume of contrast needed presents an additional risk of nephrotoxicity in those patients with pre-existing renal impairment although one recent study reported only a transient increase of up to 20% in the serum creatinine following CT angiography. 62 The diagnostic accuracy depends on the acquisition and reconstruction parameters used. 59 Current opinion differs as to the optimal acquisition protocol and the technical factors are often a compromise, being partly dependent on the type of scanner available. [63] [64] [65] The computerised analysis of the data includes various reconstructions such as shadedsurface display, maximum intensity projections and multi-planar reformatting. These allow detailed assessment of the vasculature. It is advisable to review a combination of reconstructions and original axial images to accurately grade the stenosis and to differentiate mural calcification. 59, 66 Several studies have compared the accuracy of CT angiography with conventional and digital subtraction angiography. CT angiography is limited in its evaluation of small accessory, segmental or intrarenal arteries 60, 61 and may overestimate the degree of stenosis in a small percentage. 62, 67 However studies have shown that CT angiography is able to visualise 94 -100% of main renal arteries and 78-100% of accessory renal arteries, depending on the acquisition protocol. 60, 62, 63, 68 The technique has recently reported sensitivities and specificities for detection of significant (greater than 50%) stenosis of the main renal arteries of 100% and 97-98% respectively, 60, 63 and sensitivities and specificities for detection of significant stenoses in all renal arteries of 88-90% and 97-98%, respectively. 60, 63, 67 
Magnetic resonance angiography
Magnetic resonance angiography (MRA) is emerging as a promising non-invasive tool to diagnose RAS (Figure 4 ). It has significant advantages over both intra-arterial angiography and CT angiography in that it does not use either ionising radiation or iodinated contrast media. Magnetic resonance imaging (MRI) has been in use for general clinical imaging for more than 15 years but the clinical development of the technique for imaging vessels (MRA) is a more recent innovation. The image produced in MRI depends on differences in behaviour between tissues when placed in a magnetic field and exposed to repeated radiofrequency pulses. These differences are of two main types known as the T1 and T2 relaxation times.
There are only a few contra-indications to MRI. In the past, the technique was often impractical for patients with claustrophobia because of the need to lie in a magnet which had a tunnel like structure. It was known to induce acute anxiety symptoms in up to 10% of people requiring abortion of scanning in approximately 1%. 69, 70 Improvements in magnet design have reduced these problems but it is still necessary for the patient to lie still during the examination. Patients with pacemakers and certain ferromagnetic aneurysm/haemostatic clips, valve replacements and metallic intra-orbital foreign bodies are unsuitable for MRI. 70, 71 There are two basic MRA methods known as timeof-flight (TOF) MRA and phase-contrast (PC) MRA. These are both flow sensitive techniques and can be acquired in either 2-D or 3-D formats. Breath holding is preferable but not essential. In TOF MRA the contrast between flowing blood and the adjacent stationary tissue depends on the inflow of fully magnetised protons into a preselected volume of saturated stationary tissue. 72 PC MRA relies on the phase change induced in moving spins as they pass through a magnetic field gradient. In addition to anatomical information, PC MRA also allows direct quantitative evaluation of flow dynamics with the intensity of flow signal being related to flow velocity. 73 In both techniques post processing with maximum intensity projections or surface rendering is required with areas of stenosis appearing as signal voids or areas of narrowing.
More recently, intra-venous contrast agents have been introduced for use with MRA. 74 These have been found to increase the diagnostic information available, particularly in patients with poor renal blood flow. The substances are gadolinium chelates which are paramagnetic. When injected they induce shortening of the T1 relaxation of the flowing blood. In practical terms this translates as a selective increase in the signal intensity in the arterial system, maximally effective during the extracellular first pass of the contrast media. In view of this, precise contrast media timing is necessary and is usually calculated following a preliminary test bolus. A fixed delay can also be used, although if inappropriately chosen there is enhancement of the renal veins which impairs interpretation by overlying the renal arteries. 74 Contrast enhanced MR angiography always requires breath-holding. The gadolinium chelates are generally well tolerated and are not nephrotoxic, this is clearly of particular importance in patients with renal impairment. The incidence of patient reactions is much lower than with conventional iodinated contrast media but they may rarely be associated with generalised warmth and local pain and there have been case reports of headache, vomiting and anaphylactoid reaction. 70 Various MRA sequences have been evaluated. In comparison with intra-arterial DSA the 2-D TOF sequence has reported sensitivities and specificities of 91-100% and 92-94% respectively for diagnosis of greater than 50% stenosis of the proximal portions of the main renal arteries. 75, 76 The 3-D TOF sequence may allow better detection of accessory renal arteries 77 and has sensitivities and specificities of 100% and 89-90% in detecting stenoses greater than 60% when compared to DSA. 77, 78 The 3-D PC MRA has been shown to be at least as accurate as DSA 79 with sensitivities and specificities of 84 -94% and 91-96% respectively in detecting a greater than 50% narrowing. 80, 81 The 3-D contrast enhanced MRA is rapidly gaining acceptance and has a sensitivity and specificity of 93-100% and 92-98% respectively in diagnosing stenoses greater than 50% compared to DSA. 81, 82, 83 The MR imaging sequences and MRA techniques available are ever increasing and evolving. A protocol involving a combination of sequences appears to be optimal for imaging the renal vasculature. 84, 85 In particular combining the 3-D contrast enhanced MRA with a 3-D PC MRA and standard T1 and T2 images would provide anatomical and pathological information about the adrenals and kidneys in addition to the presence and haemodynamic significance of renal artery lesions. 86 When gadolinium chelates have been given it is feasible to extend the examination to include MR renography and measure glomerular filtration rates thus providing further functional information.
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Conclusion
The optimum method of imaging renal artery stenosis for an individual patient depends on local circumstances. Ultrasound and Nuclear Medicine studies are both widely accessible but have limitations for use in screening for RAS. Good results have been reported for the use of CT angiography but this technique depends on the availability of a spiral CT scanner. At present the majority of patients in the United Kingdom have a diagnosis of RAS made at intra-arterial catheter angiography. We believe that the use of MR angiography for both screening and diagnosis will increase during the next decade as this equipment becomes more widely available.
